Obesity and Overweight is KILLING you Flagstaff

The obesity and overweight epidemic in Flagstaff is caused by several reasons. One reason is that many people do not eat enough fruits and vegetables. According to a study published in PubMed, only 1 in 10 adults in Flagstaff eat the recommended daily amount of fruits and vegetables. This lack of healthy foods in their diet can lead to weight gain and obesity.

Another reason for the obesity epidemic in Flagstaff is that people are not getting enough physical activity. The same study from PubMed found that less than 50% of adults in Flagstaff get the recommended amount of exercise each week. Without regular physical activity, it can be difficult for people to maintain a healthy weight. These factors combined contribute to the high rates of obesity and overweight in Flagstaff. It is important for individuals to make healthier food choices and find ways to incorporate more physical activity into their daily routine to help combat this epidemic.

Ready To Start

Flagstaff weight loss REVOLUTION with Wegovy Ozempic, Zepbound and Mounjaro

Flagstaff, Arizona is buzzing with excitement over the groundbreaking GLP1 and GIP revolution for weight loss. Scientists have discovered two new medications called semaglutide and tirzepatide that work by targeting the GLP1 and GIP hormones in the body. These hormones help regulate blood sugar levels and control appetite, making them key players in the battle against obesity. When semaglutide and tirzepatide are taken, they work by mimicking the effects of GLP1 and GIP in the body, helping to reduce hunger and increase feelings of fullness. This leads to decreased food intake, ultimately resulting in weight loss. In Flagstaff, many residents have seen fantastic results from using these medications, with some people losing significant amounts of weight and improving their overall health. The GLP1 and GIP revolution is transforming the way people approach weight loss in Flagstaff, offering a new and effective solution for those struggling to shed extra pounds.

Wegovy Ozempic, Zepbound, Mounjaro, Semaglutide, Tirzepatide, GLP1 and GIP: What is the difference?

Branded medications like Wegovy, Ozempic, Zepbound, and Mounjaro can be very expensive. Insurance companies may not want to cover them, which can make it hard for people to get the medicine they need. Even if insurance does cover it, the co-pays can still be a lot of money. It can take many months of filling out forms and waiting for insurance approval before someone can start taking the medication. On the other hand, generic medications like semaglutide and tirzepatide (GIP1/GLP) can be just as effective as the branded ones. They also cost less money, which can make it easier for people to afford. If you live in Flagstaff, you can start losing weight today with these generic options.
  • Increased energy levels
  • Improved cardiovascular health
  • Enhanced self-confidence
  • Better sleep quality
  • Reduced joint pain
  • Elevated mood stability
  • Lower blood pressure
  • Boosted immune system
  • Enhanced physical endurance
  • Improved mental clarity
  • Reduced diabetes risk
  • Greater mobility flexibility

The Game Changer

FDA-approved Wegovy®️, Ozempic®️, Mounjaro®️, Zepbound®️, Semaglutide, Tirzepatide, GLP1 and GIP weight loss medicine

It makes a BIG difference!

Watch the 60 Minutes CBS Report on FDA Approved Weight Loss Medicine

What Happens to My Body When I Loose Weight?

Losing weight can have a positive impact on your overall health and well-being. When you shed those extra pounds, you may experience better sleep quality, as excess weight can lead to sleep apnea and other sleep disorders. By achieving a healthier weight, you can reduce the strain on your joints, resulting in decreased joint pain and improved mobility. This can lead to a more active lifestyle and enhanced physical endurance, allowing you to engage in activities you may have previously avoided. In addition to physical benefits, weight loss can also have positive effects on your mental and emotional well-being. Lowering your blood pressure, cholesterol levels, and diabetes risk through weight loss can improve your overall health and reduce the risk of chronic diseases. This can lead to boosted immune system function and improved mental clarity. As a result, you may experience elevated mood stability and increased confidence. Not only will your clothes fit better and your face look slimmer, but others may perceive you as smarter and more beautiful. These physical, mental, and emotional benefits can contribute to a healthier and happier lifestyle.

Comparison of Weight Loss Medications Offered by LeadWest Medical

Medication Weight Loss Potential How It Works
Ozempic Up to 15% Regulates blood sugar and appetite
Wegovy Up to 20% Targets GLP-1 hormone for appetite suppression
Mounjaro Up to 27% Combines GLP-1 and GIP hormone action
Zepbound Varies Latest FDA-approved treatment for weight loss

Why Telemedicine is Safe and Better Solution for Weight Loss in Flagstaff

Leadwest telemedicine service in Flagstaff offers convenient options for accessing healthcare from the comfort of your own home. With online scheduling, you can easily book secure video online visits from your phone or laptop at a time that works best for you. This means no waiting in a doctor’s office, no commuting to the office, and no parking problems to worry about. In addition to the convenience of telemedicine, Leadwest also provides personalized SMS availability and coaching to support you on your health journey. Whether you’re looking to start your weight loss journey or simply need a prescription refill, our team is here to help. Plus, with the option of having medication shipped directly to your home, you can focus on your health without the hassle of picking up prescriptions in person. Take the first step towards better health and start your weight loss journey today with Leadwest telemedicine service in Flagstaff.

Ozempic, Wegovy, Semaglutide, Zepbound, Mounjaro, Tirzepatide. What Are The RESULTS Flagstaff

In Flagstaff, two popular weight loss medications, semaglutide and tirzepatide, have been making waves in the medical community. Semaglutide, a GLP-1 receptor agonist, has shown impressive results in clinical trials with an average weight loss of 15-20% over 68 weeks. This medication is particularly effective for patients with a BMI over 30 and those with obesity-related comorbidities such as type 2 diabetes. Semaglutide has minimal side effects, with the most common being gastrointestinal issues such as nausea and diarrhea. Overall, semaglutide has been successful in helping patients achieve significant weight loss and improve their overall health. On the other hand, tirzepatide is a dual GIP and GLP-1 receptor agonist that has also shown promising results in weight loss. In clinical trials, patients taking tirzepatide experienced an average weight loss of 12-15% over 52 weeks. This medication is suitable for patients with a BMI over 27 and those who struggle with food cravings and portion control. Tirzepatide has been well-tolerated by patients, with minimal side effects such as mild gastrointestinal discomfort. Overall, tirzepatide has been successful in helping patients achieve significant weight loss and improve their overall quality of life. The key difference between semaglutide and tirzepatide lies in their mechanisms of action. Semaglutide primarily targets the GLP-1 receptor, while tirzepatide targets both the GIP and GLP-1 receptors. This dual action of tirzepatide may provide additional benefits in terms of weight loss and metabolic control. Ultimately, the choice between semaglutide and tirzepatide will depend on individual patient profiles and preferences. Both medications have shown impressive results in weight loss and offer a safe and effective option for patients looking to improve their health and well-being.
Schedule Now

Our Process

Pre-Qualify Questionaire
Insurance Process

Select your Brand Medication 
and determine insurance coverage

Up to 28 days to process,
supply or coverage may be limited

Pay Out-Of Pocket

Select your GLP-1 or GIP and determine
eligibility with Out-of-Pocket Cost 

Instant approval & no wait time
Access to all GLP-1 and GIP medications

Meet your medical provider
Start your comprehensive
GLP -1 program
REgister Now

Medication Options

With Insurance

Ozempic® & Wegovy®

15% average weight loss
Patient pays Co-Pay to Pharmacy**
Weight Loss Los Alamitos
Weight Loss Los Alamitos
With Insurance

Mounjaro® & Zepbound™

20% average weight loss
Patient pays Co-Pay to Pharmacy**
Weight Loss Los Alamitos
Weight Loss Los Alamitos
Without Insurance

Semaglutide (GLP-1)

Active ingredient in Ozempic® & Wegovy®
Semaglutide
Without Insurance

Tirzepatide (GLP-1 & GIP)

Active ingredient in Zepbound® & Mounjaro®
Tirzepatide

Why Are You Still Obese and Can Not Lose Weight in Flagstaff

Patients in Flagstaff looking to achieve better results with weight loss medications can integrate diet and lifestyle changes for more effective outcomes. Leadwest Medical clinic offers support by providing practical dietary tips, suggested exercise routines, and access to local resources such as nutritionists or fitness centers. By combining these strategies with weight loss medications, patients can enhance their overall health and achieve their weight loss goals. In addition to dietary and lifestyle changes, behavior modification strategies are crucial for maintaining long-term weight loss. Leadwest Medical clinic emphasizes the importance of developing healthy habits and making sustainable changes to support weight loss efforts. By incorporating positive behaviors such as mindful eating, regular physical activity, and stress management techniques, patients can improve their overall well-being and increase their chances of long-lasting success. With the guidance and support provided by Leadwest Medical clinic, patients in Flagstaff can take control of their health and achieve sustainable weight loss results.

Common obesity related diseases

Obesity is linked to several serious health conditions, including heart disease, type 2 diabetes, and certain cancers. These diseases can lead to decreased quality of life and increased mortality.

Obesity not only strains vital organs but also impairs mobility and energy levels, making daily activities more challenging. Effective weight management is crucial for reducing the risk of these health complications.

  • Heart disease
  • Type 2 diabetes
  • Stroke
  • High blood pressure
  • Sleep apnea
  • Fatty liver disease
  • Osteoarthritis
  • Gallbladder disease
  • Certain cancers
  • Kidney disease
  • Gastroesophageal reflux disease
  • Mental health disorders

Flagstaff Residents Get Started Now Losing Weight with FDA Approved GLP1 and GIP Medicine

If you’re looking to get started with LeadWest Medical in Flagstaff, the process is simple and convenient. The first step is to fill out our pre-screening form online, which will help us understand your medical history and current conditions. Once you’ve completed the form, you can schedule a telemedicine visit from the comfort of your own home. Our telemedicine services allow you to meet with a doctor virtually, without the need to travel to a physical office. During your telemedicine visit, you’ll have the opportunity to discuss your personal history, medical conditions, and any concerns you may have. Our doctors will work with you to determine the best course of action and prescribe any necessary medications. If needed, prescriptions can be sent directly to your home or to your local pharmacy for pick up. With same-day appointments available, you can receive personalized care and treatment without the hassle of waiting weeks for an in-person visit. LeadWest Medical is dedicated to providing convenient and efficient healthcare services to all our patients in Flagstaff.
Schedule Now
Testimonials

What Clients Are Saying

See For Yourself

Weight Loss FAQs

Semaglutide is a prescription medication used to treat type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of the naturally occurring hormone GLP-1 in the body. Tirzepatide mimics the GIP pathway in addition to the GLP-1 pathway.

These medications help regulate blood sugar levels. They also slow down the rate at which food moves through the stomach, which can reduce appetite and promote weight loss.

They are typically administered as a once-weekly injection. The appropriate dose will depend on the patient’s individual needs.

They are not a substitute for a healthy diet and exercise, and should be used in conjunction with these lifestyle changes to achieve optimal results. As with any medication, it is important to talk to your healthcare provider about the potential benefits and risks of these medications and whether they are the right choice for you.

These medications are used to treat type 2 diabetes and obesity.

Type 2 diabetes: They are used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. They may be used alone or in combination with other diabetes medications.

Obesity: They are used as an adjunct to a reduced-calorie diet and increased physical activity to help promote weight loss in adults with a body mass index (BMI) of 30 or higher, or in adults with a BMI of 27 or higher who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol.
Semaglutide is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis. It is also not recommended for use in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as semaglutide may increase the risk of these conditions.

As with any medication, they should only be prescribed by a healthcare provider who has evaluated the patient’s medical history, current health status, and individual needs and goals. Patients should follow their healthcare provider’s instructions for use and attend regular follow-up appointments to monitor progress and assess the need for continued treatment.

These medications can cause side effects in some patients. Some of the commonly reported side effects include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Loss of appetite
  • Headache
  • Fatigue
  • Dizziness

These side effects are usually mild to moderate in intensity and tend to improve over time as the body adjusts to the medication. However, if these side effects persist or become severe, patients should contact their healthcare provider for further evaluation and guidance.

In rare cases, they can cause more serious side effects such as:

  • Pancreatitis (inflammation of the pancreas)
  • Hypoglycemia (low blood sugar)
  • Kidney problems
  • Gallbladder problems
  • Allergic reactions

Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, persistent nausea or vomiting, rapid heartbeat, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Up to 20% with Semaglutide and up to 27% with Tirzepatid

Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity.

Patients who stop the medication gain back on average two thirds of the weight they had lost. It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight.

If your prior authorization is declined, your insurance will not cover the cost of the prescribed medication. In this instance, you have the option to self-fund your medication via our partnered pharmacies.

If you wish to share lab results, images, or any other relevant documents with your physician, you need to log into your Charm Tracker portal. Once there, select ‘Documents’ from the options and upload your documents.

The cost details of all our plans are clearly exhibited on our website. The flat-fee displayed for each plan is the total amount you’ll be required to pay each month or contact us today.

Schedule Now
Schedule Now
Skip to content